Article
Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.
Clinical and experimental immunology - 1 Dec 2005
Tamir A, Jordan W J, Ritter M, Habib N, Lechler R I, Foster G R, Lombardi G
Abstract excerpt
Type I interferons (IFNs) are widely used therapeutically. IFN-alpha2a in particular is used as an antiviral agent, but its immunomodulatory properties are poorly understood. Dendritic cells (DCs) are the only antigen-presenting cells able to prime naive T cells and therefore play a crucial role in initiating the adaptive phase of the immune response. We studied the effects of IFN-alpha2a on DC maturation and its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
